resveratrol has been researched along with Epithelial Ovarian Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Czajkowski, M; Józkowiak, M; Nowicki, A; Pawlak, M; Piotrowska-Kempisty, H; Rolle, K; Skupin-Mrugalska, P; Wawrzyniak, D; Wierzchowski, M | 1 |
| Chen, J; Chen, JG; He, JH; He, SY; Huang, ST; Huang, ZH; Lin, WM; Ye, HY | 1 |
| Gossner, G; He, G; Kueck, AS; Kuick, RD; Liu, JR; Opipari, AW; Tan, L; Wahl, H; Wang, W | 1 |
3 other study(ies) available for resveratrol and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Liposomes; Ovarian Neoplasms; Resveratrol; Stilbenes | 2022 |
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Immune Checkpoint Inhibitors; Lactic Acid; Neoplasms; Ovarian Neoplasms; Polyphenols; Programmed Cell Death 1 Receptor; Resveratrol; Tumor Microenvironment | 2022 |
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cell Survival; Cisplatin; Female; Glucose; Glycolysis; Humans; In Vitro Techniques; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |